Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone in localization-related epilepsy
NCT01496612Phase 2Terminated
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Nov 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in epilepsy, sponsored by National Institute of Neurological Disorders and Stroke. Started Nov 2011; status: terminated.
02
Drugs
buspirone
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01496612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496612.